During the disclosure period of the annual report, a large proportion of dividends came again.
On February 27, Sino Biological Inc(301047) disclosed the announcement of the plan for profit distribution and conversion of capital reserve into share capital in 2021. According to the announcement, the company plans to distribute cash dividends of 100 yuan (including tax) for every 10 shares, totaling 680 million yuan; It also increased 9 shares for every 10 shares to all shareholders, with a total of 61.2 million shares. After the increase, the total share capital of the company was 129 million shares.
In addition to Sino Biological Inc(301047) , as of press time, 8 companies have disclosed relevant announcements of annual profit distribution plans. For example, Dongpeng special drink announced that it plans to pay 15 yuan (including tax) for every 10 shares to all shareholders.
one year’s profit is almost divided
Sino Biological Inc(301047) proposed cash dividend of 680 million
On the evening of the 27th, Sino Biological Inc(301047) 2021 annual report officially announced that the company achieved an annual operating revenue of 965 million yuan, a year-on-year decrease of 39.53%, including 359 million yuan of non covid-19 virus related business revenue, a year-on-year increase of 41.41%; The net profit attributable to shareholders of listed companies was 720 million yuan, a year-on-year decrease of 36.15%; The net cash flow from operating activities was 642617800 yuan, a year-on-year decrease of 41.20%.
Sino Biological Inc(301047) pointed out that the decline of the company’s overall performance in 2021 was mainly due to covid-19 virus related business, which maintained a sustained and rapid growth due to changes in the epidemic situation, prevention and control policies, market competition and other factors.
Compared with the results of the annual report, the announcement of the profit distribution and the plan for converting capital reserve into share capital disclosed on the same night attracted more attention.
According to the announcement, the company plans to distribute cash dividends of 100 yuan (including tax) for every 10 shares, totaling 680 million yuan; It also increased 9 shares for every 10 shares to all shareholders, with a total of 61.2 million shares. After the increase, the total share capital of the company was 129 million shares.
Pay a dividend of 100 yuan for every 10 shares, which belongs to the “top” in the A-share market, catching up with Kweichow Moutai Co.Ltd(600519) . In addition, the company’s total dividend was 680 million yuan, a difference of only 40 million from last year’s annual net profit.
Sino Biological Inc(301047) pointed out that the dividend scheme is based on the company’s sustained and stable profitability, good financial condition and good expectations for future development. At the same time, considering the company’s sufficient capital reserve, combined with the company’s development strategy, development stage and relatively small capital stock scale, in order to optimize the company’s capital stock structure and enhance stock liquidity, And fully consider the interests and reasonable demands of small and medium-sized investors, take into account the return of shareholders and the development of the company, and formulate the plan under the condition of ensuring the healthy and sustainable development of the company.
securities companies predict that the company’s performance is difficult to exceed 2020 in the short term
Sino Biological Inc(301047) is a biotechnology company engaged in the R & D, production, sales and technical services of biological reagents. Its main business includes products such as recombinant proteins, antibodies, genes and culture media, as well as services such as the development of recombinant proteins and antibodies and biological analysis and detection.
In recent years, the global epidemic has continued to spread. A series of biological reagent products such as virus related proteins and antibodies have been purchased by customers outside China, and the business performance has increased significantly. Among them, in 2020, the company’s revenue and net profit attributable to the parent company increased by 7.83 times and 29.97 times respectively.
Due to the high base in 2020, the company’s revenue and net profit declined in 2021, but in terms of absolute scale, it is still at a high level, 5.33 times and 19.77 times higher than that in 2019 respectively.
For the future development of the company, it is quite difficult for securities companies to predict that the revenue and profit in recent years will exceed that in 2020.
Zhongtai Securities Co.Ltd(600918) according to the Research Report at the beginning of January this year, the company’s revenue from 2021 to 2023 is expected to be 1.027 billion, 838 million and 878 million yuan, with a year-on-year increase of – 35.62%, – 18.47% and 4.76%, and the net profit attributable to the parent company is 613 million, 430 million and 402 million yuan, with a year-on-year increase of – 45.68%, – 29.81% and – 6.40%, corresponding to EPS of 901, 632 and 592.
According to the Research Report of Kaiyuan securities, based on the characteristics of the industry and the needs of end customers, we are optimistic about the long-term development of a platform company that has an independent biotechnology platform and can provide a variety of biological reagent product lines and a rich number of varieties. We estimate that the operating revenue from 2021 to 2023 will be 1.074 billion / 885 million / 949 million yuan respectively, the net profit attributable to the parent company will be 684 million / 506 million / 459 million yuan respectively, and the EPS will be 10.06/7.44/6.75 yuan respectively.
several companies disclosed profit distribution plans on the same day
On the evening of the 27th, in addition to Sino Biological Inc(301047) , as of the press time, eight companies have disclosed the relevant announcements of the annual profit distribution plan.
For example, Dongpeng special drink plans to distribute a cash dividend of 15 yuan (including tax) to all shareholders for every 10 shares. Based on this calculation, it plans to distribute a total cash dividend of 600 million yuan (including tax).
Henan Liliang Diamond Co.Ltd(301071) plans to distribute cash dividends of RMB 10 (tax included) to all shareholders for every 10 shares, with a total of RMB 60.372 million (tax included); At the same time, the capital reserve shall be used to increase 10 shares for every 10 shares to all shareholders.
Rianlon Corporation(300596) plans to distribute cash dividends of RMB 3.06 (tax included) to all shareholders for every 10 shares Jiangsu Baichuan High-Tech New Materials Co.Ltd(002455) plans to distribute cash dividends of RMB 0.50 (including tax) for every 10 shares to all shareholders Relevant report
33000 investors receive “heroic” red envelopes! Every 10 shares is 100 yuan, and the annual profit is basically divided! The actual controller took half
